Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1074 studies found for:    "Hepatitis C, Chronic"
Show Display Options
Rank Status Study
21 Terminated
Has Results
Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)
Condition: Hepatitis C, Chronic
Interventions: Biological: Peginterferon alfa-2b (PegIFN-2b);   Drug: Comparator: Stronger neo minophagen C (SNMC)
22 Unknown  Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: PEG-rIL-29;   Drug: Peginterferon alfa-2a;   Drug: Ribavirin
23 Completed
Has Results
A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin
24 Completed A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Copegus (ribavirin);   Drug: peginterferon alfa-2a [Pegasys]
25 Completed
Has Results
Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Biological: Peginterferon alfa-2b (PEG);   Drug: Ribavirin (RBV);   Drug: Placebo;   Drug: Boceprevir
26 Completed
Has Results
Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011)
Condition: Hepatitis C, Chronic
Interventions: Biological: Peginterferon alpha;   Drug: Ribavirin
27 Recruiting Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients
Condition: Hepatitis C, Chronic
Intervention:
28 Completed
Has Results
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
Condition: Hepatitis C, Chronic
Interventions: Drug: Conventional Interferon;   Drug: Peginterferon Alfa-2a;   Drug: Peginterferon Alfa-2b;   Drug: Ribavirin
29 Completed A Pharmacokinetics/Pharmacodynamics Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104AM2)(COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa 2b;   Drug: ribavirin;   Drug: SCH 900518;   Drug: ritonavir
30 Completed A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin
31 Completed
Has Results
Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir (SCH 503034);   Biological: Pegylated interferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908);   Drug: Boceprevir placebo
32 Completed APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin
Condition: Hepatitis C, Chronic
Interventions: Drug: Pegylated interferon (PEG-INF) alfa-2a;   Drug: Ribavirin
33 Completed A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection
Condition: Hepatitis C, Chronic
Intervention: Drug: Celgosivir
34 Completed
Has Results
Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685)
Condition: Hepatitis C, Chronic
Interventions: Drug: Combination of pegylated interferon alfa-2b (PEG-Intron®) and ribavirin (Rebetol®);   Drug: Combination of pegylated interferon alfa-2b and ribavirin
35 Completed Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
36 Completed An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
37 Completed 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study
Condition: Hepatitis C, Chronic
Intervention: Drug: Previous treatment in DEB025 study
38 Completed An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
39 Recruiting An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
40 Completed
Has Results
A Study of Peginterferon Alfa-2a (Pegasys) When Administered in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC)
Condition: Hepatitis C, Chronic
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.